Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies
American Journal of Hematology · 2024
DOI: 10.1002/ajh.27181 ↗Kurz gefasst
Leserbrief in der Zeitschrift American Journal of Hematology, 2024. Verfasst von Rena Buckstein und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Myelodysplastic Syndromes, Outpatients. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Canadian Cancer Society Research Institute, NHSBT R&D, the Australian and New Zealand Society of Blood Transfusions (ANZSBT).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
- Department of Pathology and Molecular Medicine, Kingston Health Sciences Center, Kingston, Ontario, Canada.
- Department of Medicine, Princess Margaret Hospital, United Health Network, Toronto, Ontario, Canada.
- Department of Medicine, University of York, York, UK.
- Department of Medicine, Mcmaster University, Hamilton, Ontario, Canada.
- Mcmaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
ORCID-Profile: Rena Buckstein, Matthew Cheung, Lee Mozessohn, Zoe McQuilten
Förderung
- Canadian Cancer Society Research Institute
- NHSBT R&D
- the Australian and New Zealand Society of Blood Transfusions (ANZSBT)
- the Wellington Division of New Zealand Cancer Society
- MOSPI Fund
- Australian and New Zealand Society of Blood Transfusion
Zitieren
APA
Buckstein, R., Callum, J., Prica, A., Bowen, D., Wells, R. A., Leber, B., Heddle, N., Chodirker, L., Cheung, M., Mozessohn, L., Yee, K., Gallagher, J., Parmentier, A., Jamula, E., McQuilten, Z., Wood, E. M., Weinkov, R., Zhang, L., Mamedov, A., …, & Lin, Y. (2024). Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies. American Journal of Hematology. https://doi.org/10.1002/ajh.27181
Vancouver
Buckstein R, Callum J, Prica A, Bowen D, Wells RA, Leber B, et al. Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies. American Journal of Hematology. 2024. doi:10.1002/ajh.27181
BibTeX
@article{Buckstein2024,
author = {Buckstein, Rena and Callum, Jeannie and Prica, Anca and Bowen, David and Wells, Richard A and Leber, Brian and Heddle, Nancy and Chodirker, Lisa and Cheung, Matthew and Mozessohn, Lee and Yee, Karen and Gallagher, Jennifer and Parmentier, Anne and Jamula, Erin and McQuilten, Zoe and Wood, Erica M and Weinkov, Robert and Zhang, Liying and Mamedov, Alex and Stanworth, Simon J and Lin, Yulia},
title = {Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies},
journal = {American Journal of Hematology},
year = {2024},
doi = {10.1002/ajh.27181}
}
EUVIMED